Utilizing first void urine for high-risk HPV testing for cervical cancer screening in HIV-positive women in Katete, Zambia
Abstract Background The World Health Organization targets to screen 70% of women worldwide twice for cervical cancer by the year 2030, first by age of 35, and again by the age of 45. However, with the current low screening coverage in many developing countries, this may not be achieved because the i...
Main Authors: | Marian Kaoma, Oladapo Olayemi, Mwila Hilton Mwaba, Kapembwa Sikwewa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | BMC Women's Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12905-023-02212-7 |
Similar Items
-
HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity
by: Laura Téblick, et al.
Published: (2024-12-01) -
Concentration strategies for spiked and naturally present biomarkers in non-invasively collected first-void urine
by: Laura Téblick, et al.
Published: (2024-02-01) -
Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine
by: Laura Téblick, et al.
Published: (2021-04-01) -
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study
by: Marianna Martinelli, et al.
Published: (2022-12-01) -
Study to determine concordance between high-risk human papilloma virus DNA detection in self collected first voided urine samples and health-care worker collected cervical samples in a subset of women with proven histopathological precancerous and cancerous lesions of the cervix
by: Shashank Purwar, et al.
Published: (2023-01-01)